News | Breast Imaging | December 02, 2016

Volpara Solutions Launches VolparaEnterprise 2.0 Software at RSNA 2016

Software helps breast imaging providers deliver high-quality, personalized breast screening and comply with the FDA EQUIP program

Volpara Solutions, VolparaEnterprise 2.0, breast imaging software, RSNA 2016

December 2, 2016 — Volpara Solutions announced the launch of VolparaEnterprise 2.0 software, which helps breast imaging providers deliver high-quality, personalized breast screening, at the 102nd Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 2, 2016.

VolparaEnterprise software, which was commercially launched in 2016, delivers key performance indicators (KPIs) for hundreds of performance and quality metrics, including positioning, compression and equipment utilization. The Microsoft Azure–based solution provides continuous quality assurance and performance monitoring through dynamic, interactive dashboards. Updated with every mammography or tomosynthesis exam, the VolparaEnterprise ConstantQuality metrics may help facilities comply with the U.S. Food and Drug Administration’s (FDA's) new EQUIP inspection program.

Designed to support large or small enterprises, VolparaEnterprise software enables breast imaging providers to provide objective evidence to demonstrate compliance and quality of care. Users can perform rapid quality control checks to optimize the productivity and efficiency of imaging resources, to help reduce costs through the reduction of retakes, and to increase staff effectiveness.

Updates to VolparaEnterprise 2.0 software include additional data and analytics tools to help improve imaging providers' understanding of their performance and provide better understanding of their patient population and referral patterns. A new technologist-specific dashboard enables technologists to monitor their own performance, and the new technologist Quality Quadrant diagram summarizes staff performance on patient positioning and compression to identify training opportunities. A broader use of infographics makes data easier to interpret, and new role-specific "landing pages" summarize performance data for each user. 

"VolparaEnterprise has given us the ability to monitor performance and quality every single day. With real-time, objective information, we no longer have to wait for ACR accreditation or for a radiologist to complain about inferior images to learn about quality concerns" said Mindy Shikiar, VP of operations at Boca Raton Regional Hospital. "We are now beginning to use VolparaEnterprise to reshape the training of our technologists. VolparaEnterprise contains this amazing capability for analyzing patient positioning, which now gives us the ability to objectively identify which technologists are doing well and offer additional training to those who may need it."

VolparaEnterprise software provides Clinical Quality Measures (CQMs1) sought by payers to justify supplemental screening. The objective assessment of volumetric breast density helps reduce time spent by radiologists and technologists on recalls that are not clinically beneficial, such as ultrasound on Breast Imaging-Reporting and Data System (BI-RADS) A/B breasts inadvertently deemed "dense" due to subjective assessment of density. This not only results in better patient care, but preserves proper equipment utilization, staff workflow and productivity.

"In the end, it's all about our patients. We were already proud to offer the Boca Raton community an amazingly well equipped and staffed breast center with dedicated professionals who truly care about our patients' well-being and long-term health. Adding VolparaEnterprise software has enabled us to implement new quality processes that will help ensure that every woman's mammogram is the best that we can offer," said Kathy Schilling, M.D., medical director of Boca Raton Regional Hospital's Christine E. Lynn Women's Health & Wellness Institute.

For more information: www.volparasolutions.com

Related Content

SmartCurve technology, a revolutionary breast imaging technology designed specifically for the curvature of the female breast to provide every woman with a more comfortable and accurate mammogram.
News | Mammography | September 14, 2018
Solis Mammography declared September Breast Wellness Month a
breast screening
News | Clinical Trials | September 13, 2018
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the a
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
Feature | Breast Imaging | September 07, 2018 | By JoAnn Pushkin
If you are confused about the conflicting advice surrounding mammography screening guidelines, welcome to the club.
Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...